Give.org logo
Support Give.org
Support Give.org
CHARITY REVIEW
Issued: February 2024 Expires: February 2026

Cure Alzheimer's Fund

Accredited Charity
Accredited Charity

Meets Standards
Accreditation seal
(781) 237-3800
34 Washington Street, Suite 310
Wellesley Hills, MA, 02481
https://curealz.org/
📄 Full Report 🖨️ Print 📋 BBB Charity Standards

Standards For Charity Accountability

Governance

  1. Board Oversight
  2. Board Size
  3. Board Meetings
  4. Board Compensation
  5. Conflict of Interest

Measuring Effectiveness

  1. Effectiveness Policy
  2. Effectiveness Report

Finances

  1. Program Expenses
  2. Fundraising Expenses
  3. Accumulating Funds
  4. Audit Report
  5. Detailed Expense Breakdown
  6. Accurate Expense Reporting
  7. Budget Plan

Fundraising & Info

  1. Truthful Materials
  2. Annual Report
  3. Website Disclosures
  4. Donor Privacy
  5. Cause Marketing Disclosures
  6. Complaints

Cure Alzheimer's Fund meets the 20 Standards for Charity Accountability.

Stated Purpose:
"to fund research with the highest probability of slowing, stopping or reversing Alzheimer's disease through venture philanthropy."

Year, State Incorporated:
2004, PA

Also Known As:
Alzheimer's Disease Research Foundation

Cure Alzheimer’s Fund (CAF) provides funds to scientists throughout the world investigating the causes of Alzheimer’s disease. Discoveries include the role of genetics through the Alzheimer’s Genome Project; the positive and negative effects of lifestyle factors including exercise, diet, sleep, and air pollution; new tools that assist with evaluating potential use in treating Alzheimer’s disease with existing approved drugs; investigation into the role of beta-amyloid; and potential diagnostic measurement tools. CAF also operates larger-scale investigations within specific areas of the science. Its consortia model provides for initiatives with funding ranging from $2 million - $7 million and an expanded level of collaboration among scientists from various research institutions. This model includes Alzheimer’s Disease Drug Discovery and Development (AD4) Consortium; Fleming APOE Consortium; Brain Entry & Exit Consortium; Collaboration to Infer Regulatory Circuits and to Uncover Innovative Therapeutic Strategies (CIRCUITS) Consortium; Neuroinflammation Consortium; and Tau Consortium.

For the year ended December 31, 2022, Cure Alzheimer's Fund's program expenses were:

Research distributions and support $24,460,315
Other program expenses $3,426,801
Total Program Expenses $27,887,116

Chief Executive
Meg Smith, Chief Executive Officer

Compensation*
$425,000

Chair of the Board
Henry F. McCance

Chair's Profession / Business Affiliation
Chairman Emeritus, Greylock Partners

Board Size
7

Paid Staff Size
32

*2023 compensation, as reported by the organization, includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.

Note: For the year ended December 31, 2022, Katharine Herman, Execuitve Vice President for Development, was the highest paid staff member receiving compensation of $355,003.

 

Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Direct mail appeals, Planned giving arrangements, Print advertisements (newspapers, magazines, etc.), Radio, Television

Fundraising costs were 5% of related contributions. (Related contributions, which totaled $32,071,318, are donations received as a result of fundraising activities.)

This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.

The following information is based on Cure Alzheimer's Fund's audited financial statements for the year ended December 31, 2022.

Source of Funds
Contributions $26,122,432
Investment income, net $8,492,261
Donated stock $5,919,199
Special events, net $306,887
Total Income $40,840,779

Programs: 91% Fundraising: 5% Administrative: 3%

Total Income $40,840,779
Total expenses: $30,582,670
  Program expenses $27,887,116
  Fundraising expenses $1,662,785
  Administrative expenses $1,033,769
  Other expenses $0
Income in Excess of Expenses $10,258,109
Beginning Net Assets $18,200,501
Other Changes In Net Assets $0
Ending Net Assets $28,458,610
Total Liabilities $1,734,174
Total Assets $30,192,784

An organization may change its practices at any time without notice. A copy of this report has been shared with the organization prior to publication. It is not intended to recommend or deprecate, and is furnished solely to assist you in exercising your own judgment. If the report is about a charity and states the charity meets or does not meet the Standards for Charity Accountability, it reflects the results of an evaluation of information and materials provided voluntarily by the charity. The name Better Business Bureau is a registered service mark of the International Association of Better Business Bureaus.

This report is not to be used for fundraising or promotional purposes.

RELATED CONTENT

Report completed by:
BBB Wise Giving Alliance